Conson Pharmaceutical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Conson Pharmaceutical - overview
Established
1994
Location
Qingdao, Shandong, China
Primary Industry
Pharmaceuticals
About
Based in Qingdao, China and founded in 1994, Qingdao Guoxin Pharmaceutical Co. , Ltd. , trading as Conson Pharmaceutical, operates as a pharmaceutical company dedicated to providing drug products. It acquired 183 invention patents and national high-tech enterprise certification.
The company's R&D centre covers an area of 9052 square meters, including a synthesis laboratory, a preparation laboratory, a pilot workshop and a quality inspection center. In January 2026, Conson Pharmaceutical raised a venture funding from Shandong Finance Investment Group. The company mainly provides marine medicine, traditional Chinese medicine, chemical medicine and health food. The product is suitable for bone metabolism regulation, cardiovascular and cerebrovascular, gastrointestinal tract, antipyretic and analgesic and other symptoms.
CP Pharmaceutical Qingdao also provides vitamin C effervescent tablets, and medications for diabetes. The company generates revenue by providing medical drugs and devices.
Current Investors
Shandong Finance Investment Group
Primary Industry
Pharmaceuticals
Sub Industries
Health Foods & Nutritional Supplements, Biopharmaceuticals, Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.zy.qdgxjt.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Conson Pharmaceutical - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Announced | Conson Pharmaceutical | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.